Anavex Life Sciences Corporation (NASDAQ:AVXL) has a beta value of 0.70 and has seen 2.68 million shares traded in the last trading session. The company,
Anavex Life Sciences Corporation (NASDAQ:AVXL) has a beta value of 0.69 and has seen 1.7 million shares traded in the last trading session. The company,
During the last session, Anavex Life Sciences Corporation (NASDAQ:AVXL)’s traded shares were 1.52 million, with the beta value of the company hitting 0.66. At the
In the last trading session, 2.01 million shares of the Anavex Life Sciences Corporation (NASDAQ:AVXL) were traded, and its beta was 0.66. Most recently the
In the last trading session, 2.87 million Anavex Life Sciences Corporation (NASDAQ:AVXL) shares changed hands as the company’s beta touched 0.71. With the company’s per
In the latest trading session, 1.54 million Anavex Life Sciences Corporation (NASDAQ:AVXL) shares changed hands as the company’s beta touched 0.71. With the company’s most
In last trading session, Anavex Life Sciences Corporation (NASDAQ:AVXL) saw 1.25 million shares changing hands with its beta currently measuring 0.65. Company’s recent per share
Anavex Life Sciences Corporation (NASDAQ:AVXL) has a beta value of 0.62 and has seen 2.12 million shares traded in the last trading session. The company,
Anavex Life Sciences Corporation (NASDAQ:AVXL) has a beta value of 0.63 and has seen 2.16 million shares traded in the last trading session. The company,
During the recent session, Anavex Life Sciences Corporation (NASDAQ:AVXL)’s traded shares were 0.9 million, with the beta value of the company hitting 0.62. At the
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
